Knox-Macaulay H H M, Ahmed M M, Gravell D, Al-Kindi S, Ganesh A
Department of Haematology, College of Medicine, Sultan Qaboos University, Muscat, Oman.
Int J Lab Hematol. 2007 Aug;29(4):292-301. doi: 10.1111/j.1365-2257.2006.00886.x.
The paucity of clinical reports in the world literature suggests that, as a disease entity, haemoglobin SE compound heterozygosity is of negligible importance. In view of the significant community prevalence of this haemoglobinopathy in the Sultanate of Oman where it is the second most prevalent sickling disorder, a hospital study of 12 SE compound heterozygotes from six unrelated Arab families was undertaken to determine their clinico-haematological features. Our findings were compared with those reviewed in the literature. Clinical and haematological evaluation was carried out by conventional methods including chromatographic haemoglobin analysis. At least 50% of those studied were asymptomatic throughout the study period but sickling-related complications occurred in the rest and included the acute chest syndrome (1/12), severe vaso-occlusive skeletal pain (2/12), frontal bossing (1/12) possibly indicative of significant chronic haemolysis and recurrent infections of the urinary tract (1/12). Steady-state haemoglobin levels fell within the reference range while MCV and MCH values were, as expected, reduced in most cases; nevertheless, concomitant inheritance of alpha-thalassaemia trait was also likely. Red cell morphology was striking by the absence or rarity of pseudo-sickled cells in the blood films of many patients during the steady state and in crises. Bearing in mind the prevalence of 0.05% of SE compound heterozygosity in Oman, the findings in this single study of the largest number of SE patients and their relatives confirm the predominantly asymptomatic nature of this sickling disorder in individuals in the community at large. HbF levels do not appear to explain the heterogeneous nature of this haemoglobinopathy. Correlation of the variable clinical and haematological features of SE cases with their alpha-globin gene status and beta-cluster haplotypes (linked to the beta(s)- and beta(e)-genes) merits a separate investigation, which is being currently organized.
世界文献中临床报告的匮乏表明,作为一种疾病实体,血红蛋白SE复合杂合性的重要性可忽略不计。鉴于这种血红蛋白病在阿曼苏丹国社区的显著流行率,它是第二大最常见的镰状细胞病,因此对来自六个不相关阿拉伯家庭的12名SE复合杂合子进行了一项医院研究,以确定他们的临床血液学特征。我们的研究结果与文献中综述的结果进行了比较。通过包括色谱血红蛋白分析在内的传统方法进行了临床和血液学评估。在整个研究期间,至少50%的研究对象无症状,但其余患者出现了与镰状细胞相关的并发症,包括急性胸综合征(1/12)、严重的血管闭塞性骨骼疼痛(2/12)、额部隆起(1/12),可能提示存在明显的慢性溶血以及复发性尿路感染(1/12)。稳态血红蛋白水平在参考范围内,而大多数情况下MCV和MCH值如预期那样降低;然而,也可能存在α地中海贫血特征的伴随遗传。许多患者在稳态期和危机期的血片中缺乏或罕见假镰状细胞,红细胞形态引人注目。考虑到阿曼SE复合杂合性的流行率为0.05%,这项对数量最多的SE患者及其亲属的单一研究结果证实,在广大社区个体中,这种镰状细胞病主要表现为无症状。HbF水平似乎无法解释这种血红蛋白病的异质性。SE病例的可变临床和血液学特征与其α珠蛋白基因状态和β簇单倍型(与β(s)-和β(e)-基因连锁)之间的相关性值得单独研究,目前正在组织这项研究。